R
Retina Consultants of Hawaii | Aiea, HI
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ranibizumab
EYP-1901
Aflibercept
Triamcinolone Acetonide
Faricimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 7 total trials
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Enrolling
Wet Age Related Macular Degeneration
wAMD
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901
Trial sponsors
E
L
T
G
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems